Digital polymerase chain reaction (dPCR) is an advancement of traditional PCR which is used to detect and quantify DNA or a targeted part of DNA molecule.
In 2017, North America dominated the dPCR market owing to the increasing number of R&D activities by major pharmaceutical companies in the region. Europe held second in the market followed by North America owing to the rising geriatric population. Asia-Pacific is projected to witness the fastest growth during the forecast period owing to the rising R&D expenditure of life sciences sector in various developing countries such as China and India.

Market Analysis and Insights: Global Digital PCR Market
The global Digital PCR market size is projected to reach US$ 54 million by 2027, from US$ 39 million in 2020, at a CAGR of 4.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital PCR market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Digital PCR market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Digital PCR market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Digital PCR market.

Global Digital PCR Scope and Market Size
Digital PCR market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital PCR market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Microreactor/Orifice Plate Digital PCR
Microfluidic Chip Digital PCR
Droplet Digital PCR

Segment by Application
Early Study of Tumor
Quantitative Analysis of A New Generation Sequencing Library
Gene Expression Analysis
Pathogen Detection
Prenatal Diagnosis
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffman-LA Roche Ltd.
Qiagen N.V.
Agilent Technologies, Inc.
Takara Bio, Inc.
Biomérieux S.A.
Affymetrix, Inc.
Fluidigm Corporation
Raindance Technologies, Inc